“CRISPR-Cas9 Genomic Editing as an Innovation in the Management of Sickle Cell Disease: A Systematic Review” (2023) American Journal of Medical Science and Innovation, 2(2), pp. 44–56. doi:10.54536/ajmsi.v2i2.1760.